STOCK TITAN

Psyched Wellness Ltd Stock Price, News & Analysis

PSYCF OTC

Welcome to our dedicated page for Psyched Wellness news (Ticker: PSYCF), a resource for investors and traders seeking the latest updates and insights on Psyched Wellness stock.

Psyched Wellness Ltd. (PSYCF) news covers the company’s ongoing work as a Canadian-based health supplements and life sciences business focused on Amanita muscaria-derived products. Updates frequently describe progress on AME-1, the company’s proprietary extract of Amanita muscaria, and its use in health and wellness consumer packaged goods.

Investors following Psyched Wellness can expect news about product launches and brand extensions, such as the Calm flagship product, the higher-potency Calmer offering, the Santa dietary supplement shot and Fly (Agaric) Amanita muscaria gummies. Releases also discuss the development of Amanita muscaria-derived water-based extracts, teas and capsules aligned with stress relief, relaxation and sleep-related objectives.

Company communications highlight scientific and regulatory milestones, including genotoxicity studies on AME-1, accelerated stability testing that supports shelf-life decisions, and a New Dietary Ingredient Notification submitted to the U.S. Food and Drug Administration. News items may also address patent filings, such as a scaled-up extraction process application, and collaborations with partners like Zerkalo LLC and the U.S. subsidiary AME Wellness Inc. on new product formats.

Operational and commercial updates are another recurring theme, including retail partnerships and distribution with specialty retailers, engagement of UNFI for distribution, direct-to-consumer initiatives and supply chain developments at third-party manufacturing facilities. Governance and corporate developments, such as management changes, option grants and board appointments, are also reported. For investors and observers, the Psyched Wellness news feed provides an ongoing view into how the company is advancing AME-1-based products, managing regulatory interactions and expanding its presence in the functional mushroom and health supplements space.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.99%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.11%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.23%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.74%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.94%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.64%
Tags
partnership
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.95%
Tags
management
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.62%
Tags
private placement
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.04%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.7%
Tags
none

FAQ

What is the current stock price of Psyched Wellness (PSYCF)?

The current stock price of Psyched Wellness (PSYCF) is $0.0081 as of April 2, 2026.

What is the market cap of Psyched Wellness (PSYCF)?

The market cap of Psyched Wellness (PSYCF) is approximately 3.7M.

PSYCF Rankings

PSYCF Stock Data

3.66M
270.30M
Packaged Foods
Consumer Defensive
Link
Canada
Toronto

PSYCF RSS Feed